JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This article presents a protocol based on Hydra — a web-based system for clinical decision support that integrates a full and detailed set of functionalities and services required by physicians for complete cardiovascular analysis, risk assessment, early diagnosis, treatment, and monitoring over time.

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death throughout the world. The total risk of developing CVD is determined by the combined effect of different cardiovascular risk factors (e.g., diabetes, raised blood pressure, unhealthy diet, tobacco use, stress, etc.) that commonly coexist and act multiplicatively. Most CVDs can be prevented by an early identification of the highest risk factors and an appropriate treatment. The stratification of cardiovascular risk factors involves a wide range of parameters and tests that specialists use in their clinical practice. In addition to cardiovascular (CV) risk stratification, ambulatory blood pressure monitoring (ABPM) also provides relevant information for diagnostic and treatment purposes. This work presents a list of protocols based on the Hydra platform, a web-based system for clinical decision support which incorporates a set of functionalities and services that are required for complete cardiovascular analysis, risk assessment, early diagnosis, treatment and monitoring of patients over time. The program includes tools for inputting and managing comprehensive patient data, organized into different checkups to track the evolution over time. It also has a risk stratification tool to compute a CV risk factor based upon several risk stratification tables of reference. Additionally, the program includes a tool that incorporates ABPM analysis and allows the extraction of valuable information by monitoring blood pressure over a specific period of time. Finally, the reporting service summarizes the most relevant information in a set of reports that aid clinicians in their clinical decision-making process.

Introduction

Cardiovascular diseases (CVDs) are a group of disorders of the circulatory system that constitute the leading cause of disability and premature death throughout the world1,2. According to the World Health Organization (WHO), an estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths1,2. There are many risk factors for CVDs, including behavioral factors such as tobacco use, an unhealthy diet, harmful use of alcohol and inadequate physical activity as well as physiological factors, including raised blood pressure (hypertension), high cholesterol or elevated blood glucose, among others2,3. Hypertension represents a major risk factor for premature cardiovascular disease, being responsible for a high level of cardiovascular morbidity and mortality4,5. Furthermore, it is estimated that the incidence of hypertension among adults in developed countries is almost 40%6,7,8. However, it remains widely undetected, undertreated and poorly controlled3,4.

CVD is a major public health problem which imposes a significant economic burden on any given health-care system6. Early identification of the highest cardiovascular risks and appropriate treatment can prevent clinical events and premature deaths4,5. Hence, there are noticeable health and economic gains attached to comprehensively and thoroughly tracking all these factors. The total risk of developing a CVD is determined by the combined effect of cardiovascular risk factors2,4,5, which commonly coexist and act multiplicatively. Therefore, a total-risk approach is advisable for early detection, as well as for clinical decision-making on the intensity of preventive interventions. Thus, morbidity, early mortality and disability could be reduced and the quality of life could be improved in individuals with an elevated total CVD risk2.

The diagnosis of CVDs is determined by the analysis of a wide range of parameters that are gathered by different procedures used by physicians in their clinical practice. The assessment of these parameters allows the computation of a total CV risk factor which is useful for diagnostic and treatment purposes2,4,5. In addition to the stratification of CV risks, ambulatory blood pressure monitoring (ABPM)9 also provides valuable information. The ABPM test allows the tracking of the patient's blood pressure (BP) during their daily routine, avoiding the influence of the clinical setting (white coat syndrome). Thus, a reliable set of measurements is obtained, allowing the extraction of additional information that supports the clinical decision-making process.

Therefore, the analysis of the cardiovascular system involves a large amount of data, entailing a tedious and time-consuming task that complicates diagnosis and treatment prescription. In this regard, the availability of a patient's full profile that gathers all the required data together with a set of automated services to extract the necessary information would be a significant improvement to guide clinicians in their decision-making process. Apart from this, the availability of an accessible platform that centralizes all patient information not only enables collaboration among different specialists from different locations but also allows discussion of debatable cases and provides reliable diagnoses.

In recent years, the use of computer-based applications and telemedicine has increased considerably, playing an important role in improving public health and welfare in all sectors of the population. This is due to their ability to extract relevant and useful information for the early diagnosis and treatment of several diseases10. The use of these tools improves the quality of health-care services, thus conveniently and reliably satisfying patient demand as well as reducing costs11. As a reference, the number of global imaging-based procedures has risen considerably, given the increasing availability of medical equipment and more sophisticated capture devices. Therefore, Lundberg et al.12 proposed a telemedicine tool to assess digital image quality and agreement between examiners in the field of the otorhinolaryngology. Ortega et al.13 developed SIRIUS, a computer-aided diagnosis framework for the analysis of retinal images. Novo et al.14 also presented their platform for the analysis of retinal microcirculation in combination with carotid macrocirculation.

With regard to CV assessment, there has been a steady increase in the number of tools available throughout the years. Some of the utilities are designed to predict cardiovascular disease risk — such as the tool proposed by Paredes et al.15 — or to calculate risk online by implementing the algorithm proposed by Goff et al.16 according to a guideline on the assessment of cardiovascular risk to calculate the 10-year risk of heart disease. Other systems are designed to be used with mobile phones, such as the proposal of Sufi et al.17 that identifies diseases from body sensors, the device designed by Lin et al.18 for tracking the electrocardiogram in order to detect the presence of abnormal rhythms and send an alarm, the app from Lee et al.19 for monitoring breathing and heart rate values while a person exercising or the application implemented by Kang and Park20 to manage raised blood pressure on the basis of clinical guidelines.

The available utilities are mainly designed to satisfy patient demand in specific scenarios. On the other hand, this article describes a protocol based on Hydra21, a platform focused on the analysis of the cardiovascular system, that is designed entirely to support specialists in their clinical decision-making process. This tool incorporates a set of functionalities and services that physicians require for reliable cardiovascular analysis including risk assessment, early diagnosis, treatment prescription and the monitoring of patients over time. Therefore, there is a tool for the input and management of patient data recorded in different checkups. Then, a risk stratification tool automatically provides a CV risk factor based on different risk stratification tables of reference. In addition to this, the ABPM analysis tool allows the extraction of valuable information from the analysis of blood pressure recordings over a specific period of time. Finally, the most relevant information is summarized in a set of reports that guide clinicians in diagnosis and proper treatment prescription. In this way, the described protocol leads to an improvement in complete cardiovascular analysis supporting a reliable diagnosis and proper treatment. Furthermore, the presented platform allows collaboration among experts, thereby promoting clinical research.

Protocol

All procedures were conducted under institutionally approved protocols with patient consent.

1. Patient and Checkup Registration

Note: See Figure 1.

  1. Go to http://www.varpa.es/Hydra/ using any modern web browser.
  2. Use an existing account associated with a doctor to Log In to the Hydra web tool.
  3. Fill in the patient registration form including patient code, date of birth, gender and ethnicity to register a new patient. Click on the include button to fill in the family background of premature CVDs. Click on the Next button to move forward to introduce the first checkup.
    Note: These global parameters are included in patient enrollment and the information added from here relates to a specific checkup.
  4. Add a new checkup.
    Note: The input data is organized in thematic blocks. Each block includes the option to be hidden or visible. If all the information of a block is unknown, use the hidden option. Keep the option NR/DK (no response/do not know) in the fields that do not match any case. See Figure 2.
    1. Fill in the checkup date; the current date used by default.
    2. Fill in the block corresponding to patient habits such as smoking, exercise, diet, etc.
    3. Fill in the block corresponding to precedents of cardiovascular illness such as cardiopathy, acute aortic dissection, strokes, etc.
    4. Fill in the block corresponding to concomitant illnesses such as diabetes, obesity, nephropathy, etc.
    5. Fill in the block corresponding to urological records with the information related to erectile malfunction, prostatic hyperplasia, etc.
      Note: This block is enabled in the checkup form when the gender of the patient is male.
    6. Fill in the block corresponding to gynecological records with the information related to hypertension in pregnancy, menopause, the age of menopause, surgical menopause, etc.
      Note: This block is enabled in the checkup form when the gender of the patient is female.
    7. Fill in the block corresponding to anti-hypertensive treatment taken before the checkup date including the treatment type, the schedule, and the dose.
    8. Fill in the block corresponding to treatments that can alter blood pressure such as vasoconstrictors, oral contraceptives, corticosteroids, etc.
    9. Fill in the block corresponding to any other treatments such as fibrates, statins, insulin, etc.
      Note: The options to input the timetable, dose or type are only enabled when each specific treatment is selected.
    10. Click on the Next button to move forward to the second checkup form relating to the physical examination and clinical analysis.
      Note: See Figure 3.
    11. Fill in the block corresponding to the physical examination with the information related to height, weight, circumference of the dominant arm, etc.
      Note: The body mass index and the waist height index are automatically computed from the previous data.
    12. Fill in the block corresponding to blood pressure recordings such as systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse, including 1 measurement standing and 3 measurements sitting. Check the boxes related to abdominal murmurs, carotid murmur, etc.
      Note: The mean of the 3 repetitions of sitting blood pressure measurements is automatically computed.
    13. Fill in the block corresponding to the ABPM recording. Upload the ABPM file and complete the information related to the time during which the patient wore the monitor such as the hours and quality of sleep, the time of going to bed and waking up, etc.
      Note: The ABPM upload is mandatory for the block related to ABPM information to be included. If there is no ABPM file available, click on the hide button.
    14. Fill in the block corresponding to biological/analytical recordings with the information related to blood analysis such as glycemia, creatinine, ferritin, microalbuminuria, etc.
      Note: The standard units for the parameters are indicated on the checkup form, as reference.
    15. Fill in the block corresponding to the electrocardiogram recording with the information related to the different wave intensities, arrhythmia, ischemic cardiopathy, etc.
    16. Fill in the block corresponding to the echocardiogram recording with the information related to the interventricular septum, left ventricle diameter in systole, posterior wall of the left ventricle, etc.
    17. Fill in the block corresponding to other measurements such as pulse wave velocity, carotid stenosis, ankle-arm index, etc.
    18. Click on the End button to record the checkup associated with the corresponding patient on the platform.
      Note: The platform moves forward to the checkup page that includes all the introduced data. See Figure 4.
    19. Click on the Edit button to add new information or update the introduced data throughout the checkup forms. Click on the End button to go back to the checkup page.
    20. Click on the Implemented treatment button to move forward to the form and prescribe any specific treatment.
    21. Fill in the block corresponding to anti-hypertensive treatment including the dose, the schedule and the type of the prescribed treatment.
    22. Fill in the block corresponding to treatments that can affect blood pressure such as vasoconstrictors, oral contraceptives, corticosteroids, etc.
    23. Fill in the block corresponding to other treatments such as fibrates, statins, insulin, etc.
    24. Click on the Definitive report button to generate the final report. It proceeds to the checkup report including all the introduced data and the prescribed treatment.
  5. Update patient profile and perform checkup management.
    1. Click on the Find patient link on the main menu bar and insert the patient code, or press the List patients link and select the patient code to proceed to the profile of a registered patient.
    2. Click on the Update button to revise and update any patient information (except the patient code, which is fixed) in the patient profile.
    3. Click on the Revise checkup link to access the checkup report (see step 4.2).
    4. Click on the Smart report link to access a brief checkup overview (see step 4.3).
    5. Click on the ABPM report link to access an overview of the ABPM results (see step 4.4).
    6. Click on the Edit link to add new information or modify the information introduced in the checkup.
      Note: This option is available only before the generation of the definitive report.
    7. Click on the New checkup button to add a new checkup for the patient.
      Note: Consecutive checkups are automatically prefilled with the information details that were included in the previous revision. See Figure 5.

2. Risk Stratification Tables

Note: The risk stratification service provides an automatic computation of the CV risk factor based upon various risk stratification tables that are recommended in the guidelines of the European Society of Hypertension/European Society of Cardiology (ESH/ESC)22. For each of the tables, the CV risk factor is computed and recorded based upon various parameters that are uploaded in the patient profile throughout the steps of the checkup data input. The higher or lower importance of each of the tables in the analysis is provided by the specialist while ensuring that each designed stratification table pays special attention to the specific conditions of the patient.

  1. Click on the Find patient link and insert the patient code or click on the List patients link and select the patient code for a patient with existing registered checkups.
  2. From the list of checkups, click on the Revise checkup link to access the checkup report and go to the block of risk stratification tables.
  3. Click on the ESH/ESC table link to access the table page. Check the highlighted cell to get the qualitative level of cardiovascular risk. Check the recommendations and possible antihypertensive treatment related to the resulting risk. Click on the Go back link to access the general checkup report.
    Note: This decision table uses the SBP and DBP measurements together with several risk factors and diseases (age, abdominal obesity, dyslipidemia, metabolic syndrome, etc.) to provide the CV risk factor as well as recommendations or treatment23.
  4. Click on the MS table link to access the Metabolic Syndrome (MS) table page. Check the presence of MS on the basis of the Adult Treatment Panel (ATP) III criterion. Check the presence of MS on the basis of the International Diabetes Fund (IDF) 2005 criterion. Click on the Go back link to access the general checkup report.
    Note: This table uses the information related to abdominal obesity, triglyceridemia, c-HDL, BP and fasting glucose24. ATP III criterion indicates the presence of MS if 3 of the above measures are outside the tolerance levels. According to IDF 2005 criterion, MS is determined by the presence of abdominal obesity together with 2 of the other measures outside the tolerance levels.
  5. Click on the Score table link to access the Systematic Coronary Risk Evaluation (SCORE) table page. Check the highlighted cell to obtain the 10-year risk of fatal cardiovascular events. Check the color of the highlighted cell in the legend to obtain the qualitative level related to the risk. Click on the Go back link to access the general checkup report.
    Note: This table uses information related to age, gender, SBP, smoking, and cholesterol25.
  6. Click on the Framingham table link to access the table page. Check the highlighted cell in the last table to obtain the 10-year risk of suffering a coronary event (angina, heart attack, with or without symptoms, fatal or not). Click on the Go back link to access the general checkup report.
    Note: This table uses information related to the parameters of age, gender, smoking, diabetes, cholesterol, cholesterol HDL, and BP26. The highlighted cells indicate the contribution of each category to the final risk.

3. ABPM Analysis

Note: ABPM is a common test that allows the monitoring of the patient’s blood pressure throughout their daytime/nocturnal routine9. The device selected for recording ABPM measurements (see the Table of Materials) is among the few BP monitors that are officially validated by international organizations such as the British Hypertension Society (BHS) or the ESH.

  1. Put the BP monitor on the patient and check that it is operating properly by taking an initial manual measurement. Instruct the patient on how to obtain the measurements manually before going to sleep and on waking up in order to delimit the day and night recordings.
  2. After the recording period, remove the BP monitor from the patient and retrieve the ABPM file. Upload the ABMP file to the block of ABPM measurements of an existing or a new checkup related to the patient (step 1.4.13).
    Note: The monitor remains connected throughout a period of time (usually 24h or 48h) and the measurements are regularly recorded at predefined intervals (typically 15 or 30 minutes).
  3. Perform ABPM analysis.
    1. Click on the Find patient link and insert the patient code, or click on the List patients link and select the patient code of a patient with any registered checkup containing ABPM data.
    2. Click on the Revise checkup link to access the checkup report and go to the block of ABPM analysis.
    3. Click on the ABPM link to access the ABPM information display.
    4. Check the rate of valid records in the general information section to ensure that the results extracted from the ABPM file are reliable.
    5. Check the information regarding the period of time during which the patient wore the monitor such as the number of hours and quality of sleep, the time of going to sleep and waking up, etc.
    6. Check the ABPM map including the graphical representation of all the recordings, such as the SBP, DBP and pulse as well as the areas under or over the maximum normal levels for each measurement.
    7. Click on the buttons for 48h, 24h (i) or 24h (ii) to change the visualization mode for the 48 h ABPM files.
    8. Click on the means button to switch the visualization mode to an even representation of the measurements.
      Note: This visualization mode computes each point from the average among consecutive measurements in the raw data.
    9. Check the additional information extracted from the original data such as the means and standard deviations of SBP, DBP, pulse rate and pulse pressure (the difference between SBP and DBP).
    10. Check the parameters regarding BP evolution that were automatically computed by the tool: nocturnal BP drop, sleep thought, pre-waking morning surge and day/night quotient for SBP and DBP measures.
    11. Check the summary table that contains the automatically computed areas under or over the maximum clinically defined thresholds for the nocturnal and diurnal measurements of SBP, DBP, and pulse pressure.
      Note: Furthermore, the ABPM service also calculates the circadian profile from the relation between the daytime and nocturnal BP²³. This profile allows cardiovascular risks to be determined by analyzing the presence of BP deviations. The smart report (step 4.4) and the ABPM report (step 4.5) contain the information related to the circadian profile.

4. Clinical Reports

Note: The report service provides a set of reports that gather all the relevant information to support the clinical decision-making process, helping physicians in their clinical practice and promoting collaboration among experts.

  1. Click on the Find patient link and insert the patient code, or click on the List patients link and select the code of a patient with any registered checkup.
  2. Click on the Revise checkup link to access the full checkup report which contains all the data recorded during the checkup registration process grouped into the various categories.
  3. Click on the ABPM link to access the data extracted from the ABPM analysis. Click on the specific link of each risk stratification table to review all the information regarding the computation of the risk value. Click on the Go back link to return to the patient page.
    Note: The parameters that are outside their normal levels are shown in red in order to facilitate their identification. In the same way, the Yes/No fields are also marked with green or red icons for an intuitive visualization of the normal and pathological cases, respectively.
  4. Click on the Smart report link to access a brief overview of the checkup which only contains essential information.
    1. Check the summary of the risk stratification tables, containing the results that were extracted from each table. Check the ABPM graph included in the final report and click on the ABPM map link for further information. Click on the Go back link to return to the patient page.
  5. Click on the ABPM report link to access an additional smart report, in this case focused on the ABPM information and results. Check the information corresponding to the ABPM recording such as the statistical measurements extracted from the SBP, DBP, and pulse, the areas over and under the normal values, the circadian profile, etc. Click on the Go back link to return to the patient page.
    Note: The report service provides the option to print the reports or export to standard formats, such as PDF, making it easier to present the report to the patient or use it for discussions with other clinicians.

Results

The patient registration described in step 1 is carried out by filling in the form presented in Figure 1. Once the user registers a new patient, the application moves forward to introduce the first checkup, which allows the input of comprehensive patient data. Figure 2 shows a screenshot of the first form of the checkup information. Once the Next button is clicked, the application moves forward to the second chec...

Discussion

The early identification and monitoring of various cardiovascular risk factors together with an appropriate treatment are critical for the prevention of cardiovascular diseases and premature deaths. In the daily clinical routine, clinicians have to handle large amounts of diverse information to check all the different variables and parameters that affect the circulatory system. Hence, it is a tedious and time-consuming task that complicates diagnosis and treatment prescription.

The proposed pr...

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work is supported by the Instituto de Salud Carlos III of the Spanish Government and the European Regional Development Fund (ERDF) through the PI14/02161 and the DTS15/00153 research projects and Xunta de Galicia, Centro singular de investigación de Galicia accreditation 2016-2019 Ref. ED431G/01; and Grupos de Referencia Competitiva, Ref. ED431C 2016-047.

Materials

NameCompanyCatalog NumberComments
Computer with color screenN/AN/A
Internet connectionN/AN/A
Modern web broserN/AN/AGoogle Chrome, Internet Explorer, Safari, Fierfox, etc.
Blood pressure monitorSpacelabsN/ASpacelabs 90217

References

  1. Stamler, J., Stamler, R., Neaton, J. D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Archives of Internal Medicine. 153 (5), 598-615 (1993).
  2. Kannel, W., Wilson, P. An update on coronary risk factors. Medical Clinics of North America. 79 (5), 951-971 (1995).
  3. Tarride, J. E., et al. A review of the cost of cardiovascular disease. The Canadian Journal of Cardiology. 25 (6), 195-202 (2009).
  4. Wolf-Maier, K., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. The Journal of American Medical Association. 289 (18), 2363-2369 (2003).
  5. Kearney, P., Whelton, M., Reynolds, K., Muntner, P., Whelton, P., He, J. Global burden of hypertension: analysis of worldwide data. The Lancet. 365 (9455), 217-223 (2005).
  6. Hermida, R., Smolensky, H., Ayala, E., Portaluppi, F. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiology International. 32 (10), 1329-1342 (2015).
  7. Field, M. . Telemedicine: A Guide to Assessing Telecommunications in Health Care. , (1996).
  8. Charles, B. Telemedicine can lower costs and improve access. Healthcare Financical Management. 54 (4), 66-69 (2000).
  9. Lundberg, T., Westman, G., Hellstrom, S., Sandstrom, H. Digital imaging and telemedicine as a tool for studying inflammatory conditions in the middle ear - evaluation of image quality and agreement between examiners. International Journal of Pediatric Otorhinolaryngoly. 72 (1), 73-79 (2008).
  10. Ortega, M., Barreira, N., Novo, J., Penedo, M., Pose-Reino, A., Gómez-Ulla, F. Sirius: a web-based system for retinal image analysis. International Journal of Medical Informatics. 79 (10), 722-732 (2010).
  11. Novo, J., Rouco, J., Barreira, N., Ortega, M., Penedo, M. G., Campilho, A. Wivern: a Web-Based System Enabling Computer-Aided Diagnosis and Interdisciplinary Expert Collaboration for Vascular Research. Journal of Medical and Biological Engineering. 37 (6), 920-935 (2017).
  12. Paredes, S., Rocha, T., de Carvalho, P., Henriques, J., Morais, J. Matlab tool for cardiovascular disease risk prediction. Experiment@ International Conference (exp.at' 13). , 190-191 (2013).
  13. Goff, D., et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation. 137 (11), (2013).
  14. Sufi, F., Khalil, I., Tari, Z. A cardiod based technique to identify cardiovascular diseases using mobile phones and body sensors. Conference Proceedings IEEE Engineering in Medicine and Biology Society. 2010, 5500-5503 (2010).
  15. Lin, C. T., et al. An intelligent telecardiology system using a wearable and wireless ECG to detect atrial fibrillation. IEEE Transactions on Information Technology in Biomedicine. 14 (3), 726-733 (2010).
  16. Lee, H., Wang, W., Lu, S., Wu, B., Ko, L. Home-based mobile cardio-pulmonary rehabilitation consultant system. Conference Proceedings IEEE Engineering in Medicine and Biology Society. , 989-992 (2011).
  17. Kang, H., Park, H. Development of hypertension management mobile application based on clinical practice guidelines. Studies in Health Technology and Informatics. 210, 602-606 (2015).
  18. Novo, J., Hermida, A., Ortega, M., Barreira, N., Penedo, M. G., López, J. E., Calvo, C. Hydra: A web-based system for cardiovascular analysis, diagnosis and treatment. Computer methods and programs in biomedicina. 139, 61-81 (2017).
  19. Janes, H., Pepe, M., Gu, W. Assessing the value of risk predictions by using risk stratification tables. Annals of Internal Medicine. 149 (10), 751-760 (2008).
  20. Mancia, G., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 25 (6), 1105-1187 (2007).
  21. Grundy, S., Brewer, H., Cleeman, J., Smith, S., Lenfant, C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 109 (3), 433-438 (2004).
  22. Conroy, R., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal. 24 (11), 987-1003 (2003).
  23. Kannel, W., McGee, D., Gordon, T., et al. A general cardiovascular risk profile: the Framingham study. American Journal of Cardiology. 38 (1), 46-51 (1976).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

HydraCardiovascular AnalysisCardiovascular DiagnosisClinical Decision MakingRisk AssessmentEarly DiagnosisTreatmentMonitoringUser friendly DesignInternational Clinical GuidelinesHypertensionPatient RegistrationPhysical ExaminationAmbulatory Blood Pressure MonitoringCardiovascular Risk FactorRisk StratificationAnti hypertensive TreatmentMetabolic Syndrome

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved